Stephens Believes Encompass Health Corporation (NYSE: EHC) Won’t Stop Here

By Jason Carr

In a report issued on January 10, Dana Hambly from Stephens reiterated a Buy rating on Encompass Health Corporation (NYSE: EHC), with a price target of $55. The company’s shares closed yesterday at $50.51, close to its 52-week high of $52.58.

According to, Hambly is a 2-star analyst with an average return of 2.5% and a 50.0% success rate. Hambly covers the Services sector, focusing on stocks such as Capital Senior Living, Team Health Holdings, and Addus Homecare Corp.

Currently, the analyst consensus on Encompass Health Corporation is Strong Buy and the average price target is $56.75, representing a 12.4% upside.

In a report issued on January 9, Robert W. Baird also reiterated a Buy rating on the stock with a $59 price target.

Encompass Health Corporation’s market cap is currently $4.97B and has a P/E ratio of 18.37. The company has a book value ratio of 4.3692.

Based on the recent corporate insider activity of 98 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of EHC in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Impatient Rehabilitation and Home Health and Hospice segments.